Simcere Pharmaceutical Group (NYSE:SCR)

CAPS Rating: 4 out of 5

The Company is a manufacturer and supplier of branded generic pharmaceuticals in the fast growing China market.

Recs

0
Player Avatar value18 (< 20) Submitted: 10/9/2009 7:15:07 PM : Outperform Start Price: $7.44 SCR Score: -5.86

china GROWTH

Report this Post Reply

Featured Broker Partners


Advertisement